Regenics AS is a biotechnology company based in Oslo, Norway, specializing in regenerative medicine and advanced therapeutic solutions. The organization focuses on developing innovative treatments that harness the body's natural healing processes, particularly in the fields of cellular therapy and tissue engineering. With a commitment to enhancing patient outcomes, Regenics AS is at the forefront of research aimed at addressing various medical conditions through cutting-edge technology and scientific advancements.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

14 Patents

#37 in Oslo

#116 in Norway

#42,199 in the World

Oslo, Norway

Regenics as

Forward Citations = 25

5 inventors:

Jan Remmereit (13 out of 42 patents)

Runhild Gammelsaeter (13 out of 13 patents)

Gry Kalstad Lonne (1 out of 1 patent)

4. Camilla Margrethe Haglerod (1 out of 1 patent)

5. Henrik Lund (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Regenics as. Retrieved from https://idiyas.com/company/regenics-as

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

7 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]